Literature DB >> 19584102

Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan.

Ting-Shu Wu1, Hsieh-Shong Leu, Cheng-Hsun Chiu, Ming-Hsun Lee, Ping-Cherng Chiang, Tsu-Lan Wu, Ju-Hsin Chia, Lin-Hui Su, An-Jing Kuo, Hsin-Chih Lai.   

Abstract

OBJECTIVES: Mycobacterium kansasii causes a variety of infections. Although previous reports on the prognosis of antimicrobial therapy have been mostly satisfactory, problems involving treatment failure or relapse have been encountered. The purpose of this study was to establish a relationship between the clinical treatment outcomes of M. kansasii infections and bacterial drug susceptibility, and their clonality.
METHODS: A total of 37 M. kansasii clinical isolates and clinical information on 34 patients were retrospectively collected in a tertiary medical centre in Taiwan. Bacterial drug susceptibility was determined by the microdilution method. The phylogenetic relationship was analysed by PFGE analysis.
RESULTS: Results of PFGE typing revealed a major cluster (cluster I) and eight other divergent patterns. Two/three strains leading to treatment failure were also multidrug resistant and belonged to cluster I.
CONCLUSIONS: A relationship between high drug resistance and genetic relatedness of some M. kansasii strains was established. This was associated with clinical treatment failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584102     DOI: 10.1093/jac/dkp238

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.

Authors:  Zofia Bakuła; Magdalena Modrzejewska; Lian Pennings; Małgorzata Proboszcz; Aleksandra Safianowska; Jacek Bielecki; Jakko van Ingen; Tomasz Jagielski
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Correlation between variable-number tandem-repeat-based genotypes and drug susceptibility in Mycobacterium avium isolates.

Authors:  Y Tatano; C Sano; K Yasumoto; T Shimizu; K Sato; K Nishimori; T Matsumoto; S Yano; H Takeyama; H Tomioka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-12       Impact factor: 3.267

3.  Antibiotic Susceptibility and Genotyping of Mycobacterium avium Strains That Cause Pulmonary and Disseminated Infection.

Authors:  Kei-Ichi Uchiya; Shoki Asahi; Kazunori Futamura; Hiromitsu Hamaura; Taku Nakagawa; Toshiaki Nikai; Kenji Ogawa
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection.

Authors:  Chang-Chieh Chen; Sheng-Hui Tsai; Chia-Chen Lu; Shiau-Ting Hu; Ting-Shu Wu; Tsung-Teng Huang; Najwane Saïd-Sadier; David M Ojcius; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

5.  Molecular typing of Mycobacterium kansasii using pulsed-field gel electrophoresis and a newly designed variable-number tandem repeat analysis.

Authors:  Zofia Bakuła; Anna Brzostek; Paulina Borówka; Anna Żaczek; Izabela Szulc-Kiełbik; Agata Podpora; Paweł Parniewski; Dominik Strapagiel; Jarosław Dziadek; Małgorzata Proboszcz; Jacek Bielecki; Jakko van Ingen; Tomasz Jagielski
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

6.  Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.

Authors:  Vitalii Litvinov; Marina Makarova; Ksenia Galkina; Elena Khachaturiants; Maria Krasnova; Lidia Guntupova; Svetlana Safonova
Journal:  PLoS One       Date:  2018-09-17       Impact factor: 3.240

7.  Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.

Authors:  Yinjuan Guo; Yanhua Cao; Haican Liu; Jinghui Yang; Weiping Wang; Bingjie Wang; Meilan Li; Fangyou Yu
Journal:  Microbiol Spectr       Date:  2022-01-12

8.  Transposon mutagenesis in Mycobacterium kansasii links a small RNA gene to colony morphology and biofilm formation and identifies 9,885 intragenic insertions that do not compromise colony outgrowth.

Authors:  William C Budell; Gabrielle A Germain; Niklas Janisch; Zaid McKie-Krisberg; Anitha D Jayaprakash; Andrew E Resnick; Luis E N Quadri
Journal:  Microbiologyopen       Date:  2020-02-21       Impact factor: 3.139

9.  Genomic Insights Into the Mycobacterium kansasii Complex: An Update.

Authors:  Tomasz Jagielski; Paulina Borówka; Zofia Bakuła; Jakub Lach; Błażej Marciniak; Anna Brzostek; Jarosław Dziadek; Mikołaj Dziurzyński; Lian Pennings; Jakko van Ingen; Manca Žolnir-Dovč; Dominik Strapagiel
Journal:  Front Microbiol       Date:  2020-01-15       Impact factor: 5.640

10.  Incidence, Clinical Manifestation, Treatment Outcome, and Drug Susceptibility Pattern of Nontuberculous Mycobacteria in HIV Patients in Tehran, Iran.

Authors:  Seifu Gizaw Feysia; Malihe Hasan-Nejad; Siroos Amini; Gholamreza Hamzelou; Hossein Kazemian; Jalil Kardan-Yamchi; Morteza Karami-Zarandi; Mohammad Mehdi Feizabadi
Journal:  Ethiop J Health Sci       Date:  2020-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.